Replimune Group, Inc. (REPL) Q4 2025 Earnings Call Transcript

Replimune Group, Inc. (NASDAQ:REPL) Q4 2025 Results Conference Call May 22, 2025 8:00 AM ET

Company Participants

Arleen Goldenberg - Senior Communications Leader
Sushil Patel - Chief Executive Officer
Chris Sarchi - Chief Commercial Officer
Emily Hill - Chief Financial Officer

Conference Call Participants

Anupam Rama - J.P. Morgan
Roger Song - Jefferies
Jonathan Chang - Leerink
Allison Bratzel - Piper Sandler
Peter Lawson - Barclays

Operator

Good morning and welcome to the Replimune Fiscal Year Fourth Quarter 2025 Financial Results and Corporate Update Conference Call. Currently, all participants are in listen-only mode. This call is being webcast live on the investors and media section of Replimune's website at replimune.com, and a recording will be available after the call.

I would like to introduce Arleen Goldenberg from Replimune. Please go ahead.

Arleen Goldenberg

Thank you, Operator, and good morning, everyone. Thank you for joining us today for a discussion of Replimune's fiscal year fourth quarter 2025 business highlights and financial results.

Leading the call today will be Sushil Patel, our Chief Executive Officer. He will be joined by Chris Sarchi, our Chief Commercial Officer, and Emily Hill, our Chief Financial Officer. After our prepared remarks, we will open the call for Q&A an audio recording and webcast replay for today's conference call will also be available online as detailed in the press release announcement for this call.

During today's call, we will be making certain forward-looking statements, including, without limitations, statements about the potential safety, efficacy, and regulatory and clinical progress of our product candidates, our anticipated cash runway, and our future expectations, plans, partnerships and prospects. These statements are subject to various risks such as changes in market conditions and difficulties associated with research and development, and regulatory approval processes.

These and other risk factors are described in the